Carmell Therapeutics' Series B Round

Carmell Therapeutics raised a round of funding on July 11, 2017.

Carmell Therapeutics is developing biologically-active medical devices manufactured from blood plasma with growth and regenerative factors designed by nature in the right proportions to heal tissues. …

Articles about Carmell Therapeutics' Series B Round: